Justin Porter

Topgrading serves others by helping them hire well. Need proof? Check out this June workshop feedback from Jessica Garrant, Sr. Director, Operations at Lucy Therapeutics, Inc.: ·    Overall, I would rate the workshop a 10 out of 10. ·    Overall, Lyle Brambier (primary facilitator and former Topgrading client) a 10 out of 10. ·      Overall, Andy Williams (VP, Opts and secondary facilitator) a 10 out of 10. The most useful aspects of the workshop were: ·      The explanation of the "why" to everything. It is so helpful understanding WHY each step of the Topgrading interview process is done, what it helps employers avoid, as well as what it helps employers gain. ·      I attended the Topgrading Workshop with Lyle and Andy and really enjoyed it. I thought a full day virtual workshop would be hard to stay focused through, but they did a FANTASTIC job keeping everyone engaged and involved. What I appreciated most was their clear and detailed explanations of each step in the Topgrading process. They didn't just tell us what to do; they provided valuable insights into why each step is crucial in attracting and hiring top talent. Even with my 17 years as an HR Professional, I gained so much from this! I HIGHLY recommend this workshop and am so glad my executive coach suggested it! Thanks Lyle & Andy for a fun and insightful day! Two thumbs up!

7

1 Comment

Recruiting is a unique industry. If we are doing our job, we make our hiring managers look good without anyone knowing we were involved. So, I guess that makes us part 🥷 In polling out clients, it has been heartwarming to hear how our FSP and Staffing services has helped them succeed: 1. Expertise and Skill Match: Access to highly skilled and experienced professionals. Proper alignment of staff skills with specific project needs. Faster onboarding due to pre-vetted candidates. 2. Efficiency and Speed: Quicker recruitment process, reducing project delays. Immediate availability of staff for urgent or high-priority projects. 3. Cost-Effectiveness: Reduced recruitment and training costs. Flexible staffing solutions, such as temporary or project-based hires, to manage budget effectively. 4. Quality and Compliance: High-quality work due to experienced and knowledgeable staff. Improved adherence to regulatory and compliance standards. 5. Scalability and Flexibility: Ability to scale the team up or down based on project demands. Flexibility to bring in specialized expertise as needed. 6. Operational Efficiency: Streamlined hiring processes, allowing internal teams to focus on core activities. Better resource allocation and workload management. 7. Innovation and Best Practices: Introduction of new ideas and best practices from industry experts. Enhanced problem-solving capabilities due to diverse experiences. 8. Risk Management: Reduced risk of project delays and non-compliance. Mitigation of potential staffing challenges or turnover. 9. Networking and Industry Connections: Access to a broader network of professionals and industry contacts. Opportunities for partnerships and collaborations. 10. Employee Retention and Satisfaction: Higher job satisfaction due to proper job fit. Lower turnover rates due to better candidate matching. 11. Focus on Core Competencies: Internal teams can concentrate on strategic and high-value tasks. Less distraction from administrative and recruitment tasks. 12. Enhanced Reputation: Improved project outcomes enhance the company's reputation. Positive perception in the industry due to high-quality work. 13. Compliance with Employment Regulations: Assurance of compliance with employment laws and regulations. Reduced legal risks associated with hiring and employment practices. 14. Long-Term Strategic Planning: Ability to plan and execute long-term projects with the right talent. Better alignment of staffing strategy with organizational goals. 15. Adaptation to Market Changes: Agility to adapt to changes in the clinical research landscape. Ability to quickly respond to new opportunities or challenges. 🙏 for the feedback!!

12

1 Comment

Life Sciences Job Market Update: Here's How I Can Help 💡 The life sciences industry has seen its share of restructuring lately, and unfortunately, that means talented professionals are being impacted. If you've been affected by recent layoffs, know this: there are opportunities out there, and I'm here to help you find them. 🔍 Here's a quick recap of some of the companies that have undergone changes: Big Pharma: Sanofi, Novartis, Bristol Myers Squibb Biotech: Amylyx, Tessera Therapeutics, BenevolentAI, Ultimovacs, Vedanta Biosciences, Genentech, Carisma Therapeutics What can I do for you? ❓ Targeted Job Search: I can leverage my network and industry knowledge to find roles that align with your skills and experience. Resume & Interview Coaching: Let's refine your resume to highlight your strengths and prepare you to ace interviews during this competitive time. Career Guidance: Considering a career shift within life sciences? I can help you navigate your options and explore new possibilities. Don't wait! Connect with me today and let's get you back on track. 📈 #LifeSciences #Jobs #layoffs #careershift #recruiting #network

6

Catch the latest episode of the BVIE series featuring Glen Gardner from Gardner Innovation Search Partners; with host Sabah B., we discuss the journey of biotech innovations from lab to market. Discover how companies like Iron Med Tech tackle the infamous "valley of death" in their quest to bring groundbreaking solutions to life. Don’t miss out on expert insights into tech transfer challenges and the strategic moves needed to secure funding and partnerships.  Watch full episode here 👉https://lnkd.in/gpB2HFGq #OneValley #BVIE #Innovation #Entrepreneurship #StartupEnablement #GardnerISP #TechTransfer #TechnologyTransfer

21

1 Comment

What's new in healthcare hiring? Check out the latest Monster Hiring Snapshot to learn about the continued growth in both the healthcare and social assistance sectors. Despite weakened job numbers in June, demand for healthcare professionals remains strong on #Monster, which could be a sign of ongoing labor shortages and a growing skills gap. Check out the full report for more insights! #HealthcareJobs #SocialAssistance #HiringTrends

2

Here's a scenario for a candidate that I'm currently working with that is weighing up two very different roles: One opportunity is for a BD Director at a well-established company, top 3 in their market. High base and a good total comp package. The deals won't do themselves, but there's a steady flow of inbound leads and a large outbound lead gen team to book meetings. The second opportunity is high risk/high reward. It's a lower base with high commission potential the total comp would be about the same as the first opportunity. It comes with equity and if you were to believe the founder it would be a close to 7 figure payout in the next 5 years. BUT - it's a new company in a nascent area. They've closed deals, but not enough that they can 100% say there is product-market fit. They'd be responsible for self-generating all leads. Which one would you opt for and why?

4

Clinical Trials Updated: The FDA grants priority review to Tagrisso for specific subtype of NSCLC Straight after ASCO, AstraZeneca's lung cancer drug Tagrisso has received priority review from the FDA for treating unresectable Stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after chemoradiotherapy. If approved, it would be the first targeted treatment for this condition. Tagrisso showed promising results in a clinical trial, reducing the risk of disease progression or death by 84% compared to placebo. Patients taking Tagrisso had a median progression-free survival of 39.1 months compared to 5.6 months for those on placebo. Safety data was consistent with Tagrisso's known profile. AstraZeneca is seeking a fast-track approval and hopes to establish Tagrisso as a new standard treatment for this type of NSCLC. https://lnkd.in/ewtsc7Xz #oncology #medicalaffairs #clinicaldevelopment #clinicaljobs #medicaljobs

8

The current job market is highly competitive, not just for job seekers but also for employers. Here’s how to navigate talent acquisition in today’s job market:

3

Ambry is at #ACOG2024! Come see us at Booth #1400. We look forward to speaking to you about our hereditary cancer testing offerings, complete with +RNAinsight™, and demonstrating how Ambry is setting the standard in #genetictesting. #breastcancer #GYNcancer

39

Ask yourself, "What 𝙖𝙘𝙩𝙪𝙖𝙡𝙡𝙮 makes this Life Sciences job on my team appealing???” Traditional job descriptions (while functional), often read like legal documents. They keep compliance in order. Across Life Sciences, we tend to post these Job Descriptions directly to LinkedIn. With biotech roles attracting so many applicants this quarter, it's the perfect time to add specificity, clarity, and creativity to our adverts. What’s the story behind why this job is open in the first place? Why does this skills gap matter to the business right now? What kind of person are you 𝘳𝘦𝘢𝘭𝘭𝘺 hoping will apply? Job advertisements don't 𝗵𝗮𝘃𝗲 to be the same as everyone else's. You want people to stop, read, and think, “Omg - I want to be part of that.” I get it, though. Biotech companies are under a lot of pressure. You might think you don't have the time to jazz up a job ad. But: you do find time to go through over 20 interviews per opening, right? And isn't it maybeeee true that most of those candidates aren't what you're actually looking for? 🤔 🤔 ☕ 🤔 🤔 A little more legwork in your efforts before launching a role might lead to fewer, but far more suitable interviews.

31

9 Comments

The FDAs rule on Laboratory Developed Tests is officially here. What does this mean for your team? An ALKU expert can help answer that question, or assist in execution if a roadmap has already been identified. Reach out today to speak to some of the best in the industry, who exclusively consult through ALKU. #FDA #LDT #LaboratoryDevelopedTests #FDACompliance #MedicalDevice

21

What's new in healthcare hiring? Check out the latest Monster Hiring Snapshot to learn about the continued growth in both the healthcare and social assistance sectors. Despite weakened job numbers in June, demand for healthcare professionals remains strong on #Monster, which could be a sign of ongoing labor shortages and a growing skills gap. Check out the full report for more insights! #HealthcareJobs #SocialAssistance #HiringTrends

2

"Ensuring my candidates are well-informed about the job is dependent on how well I understand the job." Briana Simmons shares her approach to fully informing candidates before interviews in The Medicus Firm's latest Recruitment Spotlight. #CandidateExperience #HealthcareRecruiting #EffectiveCommunication #TalentAcquisition #EmployeeSpotlight #WeAreTMF

1

Recruiter tip: For biotech job applications, do not put graphics in your resume. We sometimes see a resume with graphs or colorful elements to describe the candidate's experience. While the candidate understands what they meant, the recruiter has no clue! What exactly is 4 out of 5 stars for cell culture experience? It leads the recruiter or manager to question a resume more than to consider it. Keep your resume format simple and clean. Boring and black-and-white is best!

20

Major Milestones in the Cell Therapy Revolution The cell therapy field is witnessing significant strides, with leading biotechs at the forefront of innovation. Let's dive into some of the latest developments: 1) Bristol Myers Squibb and bluebird bio continue to make waves with their CAR-T cell therapy Abecma, recently approved by the FDA for treating relapsed or refractory multiple myeloma patients. A pivotal advancement in the fight against this blood cancer. 2) Roche's Genentech is taking its stem cell therapy for age-related macular degeneration, a leading cause of vision loss, into Phase 3 clinical trials. The potential to restore vision through stem cell therapy is truly remarkable. 3) Tissue Tech Autologous Corp (TTIC) has demonstrated promising results with its regenerative cell therapy for chronic diabetic foot ulcers. According to FiercePharma, the therapy significantly improved healing rates in clinical trials, offering hope for reduced amputation risk. As major players like Bristol Myers Squibb, Roche, and innovative biotechs such as TTIC lead the charge, the cell therapy landscape is rapidly evolving. We could be witnessing the advent of transformative treatments that improve lives and offer new therapeutic avenues. I'm excited to see what groundbreaking advancements lie ahead in this dynamic field. Share your thoughts on these developments in the comments below and get in touch if you are interested in working on cell therapy Programs. +1 332-219-0879 or ncrowley@i-pharmconsulting.com

3

Clinical Trials Updates: Sanofi shares positive phase III trial results, hoping for a swift FDA approvals Immune Thrombocytopenia (ITP) is a serious autoimmune blood disorder characterized by low platelet counts due to autoantibody-mediated platelet destruction and impaired platelet production. Symptoms include bruising, petechiae, and in severe cases, life-threatening bleeding episodes. ITP affects about 9.5 per 100,000 adults annually and can significantly impact patients' quality of life. Treatment options traditionally include steroids, immunosuppressants, and, in severe cases, splenectomy. The LUNA 3 Phase III study evaluated rilzabrutinib, a novel oral BTK inhibitor, in adult patients with persistent or chronic ITP. Rilzabrutinib aims to address underlying mechanisms of ITP by reducing autoantibody production and platelet destruction. Rilzabrutinib demonstrated significant efficacy in achieving durable platelet response compared to placebo, particularly in patients refractory to prior therapies. Secondary endpoints also showed promising outcomes. These results suggest a potential breakthrough in ITP treatment. Rilzabrutinib's ability to improve platelet counts and potentially alleviate symptoms offers hope for patients with persistent and chronic ITP, potentially enhancing their quality of life and reducing the risk of life-threatening bleeding episodes. This novel therapy represents a significant advancement in addressing the complex challenges of ITP management. https://lnkd.in/efk39S4n #medicalaffairs #clinicaldevelopment #hematology #clinicaltrials #medicaljobs #clinicaljobs

21

1 Comment

Despite weakened job numbers in June, demand for healthcare professionals remains strong on #Monster, which could be a sign of ongoing labor shortages and a growing skills gap. Check out the full report for more insights #HealthcareJobs #SocialAssistance #HiringTrends

1